检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:鄢龙家 黎永良[1] 邓明高 陈安超 杜志云[1] 董长治[1,3] 陈惠雄 Yan Longjia;Li Yongliang;Deng Minggao;Chen Anchao;Du Zhiyun;Dong Changzhi;Chen Huixiong(Faculty of Light Industry and Chemical Engineering,Guangdong University of Technology,Guangzhou,510006,China;Biomedicale,Universite Paris Descartes,75006 Paris,France;Universite Paris Diderot,75013 Paris,France)
机构地区:[1]广东工业大学轻工化工学院,广州510006 [2]巴黎笛卡尔大学生物医学系,巴黎75006 [3]巴黎狄德罗大学,巴黎75013
出 处:《有机化学》2020年第3期731-739,共9页Chinese Journal of Organic Chemistry
基 金:国家自然科学基金(No.21672043)资助项目。
摘 要:为了寻求新型抗肿瘤药物,设计并合成了一系列新型1,3,4-噁二唑和1,3,4-噻二唑衍生物,对这些化合物在人类四种癌细胞:B-16(皮肤黑色素瘤细胞)、PC-3(人前列腺癌细胞)、U87(人原发性胶质母细胞瘤细胞)和A549(人非小细胞肺癌细胞)进行抗肿瘤活性评价.结果显示部分化合物具有较好的抗肿瘤活性,尤其是5-{6-[4-(2-羟基乙基)哌嗪-1-基]-2-甲基嘧啶-4-基氨基}-[1,3,4-噻二唑-2-羧酸(2-甲氧基苯基)酰胺(8b)]和5-{6-[4-(2-羟基乙基)哌嗪-1-基]-2-甲基嘧啶-4-基氨基}-[1,3,4-噻二唑-2-羧酸(4-甲氧基苯基)酰胺(8c)],对四种癌细胞都显示出较高的抗肿瘤活性,其抑制活性均优于阳性对照达沙替尼,随后对这类化合物抑制肿瘤的可能靶点开展了进一步研究.In order to find new anti-tumor drugs,a series of novel 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives were designed and synthesized.The target compounds were evaluated for antitumor activity in vitro on four human cancer cell lines including B-16(skin melanoma cells),PC-3(human prostate cancer cells),U87(human primary glioblastoma celis)and A549(human non-small cell lung cancer cells).The results displayed that some of the compounds had good activities,especially,(5(-6-(4-(2-hydroxyethyl)piperazin-l-yl)-2-methylpyrimidin-4-yl)amino)-N-(2-methoxyphenyl)-1,3,4-thiadiazole-2-carboxamide(8b)and 5-((6-(4-(2-hydroxyethyl)piperazin-l-yl)-2-methylpyrimidin-4-yl)amino)-N-(4-methoxyphenyl)-1,3,4-thiadiazole-2-carboxamide(8c)showed high antitumor activities against four cancer cell lines,which was better than dasatinib.These compounds were further studied for their possible target of tumor suppression.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222